Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for TAP block in laparoscopic lower abdominal tumor resection
ChiCTR2400091811Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in abdominal mass comparing Bupivacaine liposome TAPB arm with Ropivacaine TAPB arm (2 arms). Primary endpoint: Postoperative opioid use. Started Nov 2024; status: recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
abdominal mass
Beyond the preview
Go deeper on ChiCTR2400091811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091811.